Banker: Value of Closed M&A Soars in 2017 due to Mega Deals (Feb 12 – 19, 2018, Chemical Week)news2021-07-01T19:09:48+00:00February 12th, 2018|Our Publications|
Stock Market and Financing – Strong with a Twist (ICIS Chemical Business, Feb 2, 2018 issue)news2021-07-01T19:09:42+00:00February 2nd, 2018|Our Publications|
Pharma and Biotech: Strategic, M&A and Financial Yearend Review and Outlook (Pharma Exec Feb 2018 issue)news2021-07-01T19:09:36+00:00February 1st, 2018|Our Publications|
Chemical M&A – Below the Surface (ICIS Chemical Business, Jan 26, 2018 issue)news2021-07-01T19:09:30+00:00January 26th, 2018|Our Publications|
Chemical M&A and IPOs – A Warped View – Young & Partners (ICIS Chemical Business Nov. 10 – 16, 2017 issue)news2021-07-01T19:09:25+00:00November 10th, 2017|Our Publications|
The Highs, Lows and the Unexpected – Young & Partners (ICIS Chemical Business Sept 8 – 14, 2017 issue)news2021-07-01T19:09:18+00:00September 8th, 2017|Our Publications|
Pharma and Biotech Markets (Young & Partners article in Pharma Executive eBook) Sept 2017news2021-07-01T19:09:02+00:00September 1st, 2017|Our Publications|
Fire and Ice – Chemical Mergers and Acquisitions- Young & Partners (ICIS Chemical Business Sept 1 -7, 2017 issue)news2021-07-01T19:27:51+00:00September 1st, 2017|Our Publications|
Calm Before The Storm – Young & Partners (ICIS Chemical Business May 19 – 25, 2017 issue)news2021-07-01T19:27:58+00:00May 19th, 2017|Our Publications|
Pharma and Biotech Markets – Mostly Sunny, But An Uncertain Forecast (Pharmaceutical Executive May 9, 2017)news2021-07-01T19:28:49+00:00May 9th, 2017|Our Publications|
